Clinical trial
Cabozantinib in Advanced Solid Malignancies
NCT01588821
Study timeline
Study start (unknown)2012-06-01Date precision: month
Registry last updated2020-09-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerverified · MONDO: lung cancer
Interventions
CabozantinibDRUG · verified · RxNorm: cabozantinib
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01588821 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.